Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

<< < Results 11 - 20 of 134 > >>
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Show all pathways known for 1.3.98.1Display the word mapDisplay the reaction diagram Show all sequences 1.3.98.1Autoimmune Diseases 20310011 4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease. causal interaction
therapeutic application
unassigned
4
4
0
Show all pathways known for 1.3.98.1Display the word mapDisplay the reaction diagram Show all sequences 1.3.98.1Autoimmune Diseases 21861807 Recent Developments in the Medicinal Chemistry and Therapeutic Potential of Dihydroorotate Dehydrogenase (DHODH) Inhibitors. causal interaction
therapeutic application
unassigned
3
4
0
Show all pathways known for 1.3.98.1Display the word mapDisplay the reaction diagram Show all sequences 1.3.98.1Autoimmune Diseases 24801997 Fluorine modulates species selectivity in the triazolopyrimidine class of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors. therapeutic application
unassigned
3
0
Show all pathways known for 1.3.98.1Display the word mapDisplay the reaction diagram Show all sequences 1.3.98.1Autoimmune Diseases 27721149 Dihydroorotate dehydrogenase: A drug target for the development of antimalarials. causal interaction
therapeutic application
unassigned
4
4
0
Show all pathways known for 1.3.98.1Display the word mapDisplay the reaction diagram Show all sequences 1.3.98.1Autoimmune Diseases 32353424 Natural product piperine alleviates experimental allergic encephalomyelitis in mice by targeting dihydroorotate dehydrogenase. causal interaction
therapeutic application
unassigned
3
4
0
Show all pathways known for 1.3.98.1Display the word mapDisplay the reaction diagram Show all sequences 1.3.98.1Autoimmune Diseases 32696396 A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial. causal interaction
diagnostic usage
ongoing research
therapeutic application
3
1
3
4
Show all pathways known for 1.3.98.1Display the word mapDisplay the reaction diagram Show all sequences 1.3.98.1Autoimmune Diseases 33291455 IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro. ongoing research
therapeutic application
unassigned
4
4
0
Show all pathways known for 1.3.98.1Display the word mapDisplay the reaction diagram Show all sequences 1.3.98.1Breast Neoplasms 28196676 Dihydroorotate dehydrogenase (DHODH) inhibitors affect ATP depletion, endogenous ROS and mediate S-phase arrest in breast cancer cells. causal interaction
ongoing research
therapeutic application
unassigned
3
3
4
0
Show all pathways known for 1.3.98.1Display the word mapDisplay the reaction diagram Show all sequences 1.3.98.1Breast Neoplasms 28362817 Cis-eQTL-based trans-ethnic meta-analysis reveals novel genes associated with breast cancer risk. causal interaction
diagnostic usage
unassigned
3
1
0
Show all pathways known for 1.3.98.1Display the word mapDisplay the reaction diagram Show all sequences 1.3.98.1Carcinogenesis 29925003 Energy Metabolism Rewiring Precedes UVB-Induced Primary Skin Tumor Formation. unassigned 0
<< < Results 11 - 20 of 134 > >>